Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
法匹拉韦和羟氯喹联合疗法治疗中重度COVID-19患者(FACCT试验):一项开放标签、多中心、随机、对照试验
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-021-00496-6
Bosaeed, Mohammad; Mahmoud, Ebrahim; Alharbi, Ahmad; Altayib, Hadeel; Albayat, Hawra; Alharbi, Faisal; Ghalilah, Khalid; Al Arfaj, Abdulmajid; AlJishi, Jumana; Alarfaj, Abdullatif; Alqahtani, Hajar; Almutairi, Badriah M; Almaghaslah, Manar; Alyahya, Nawaf M; Bawazir, Abdullah; AlEisa, Saud; Alsaedy, Abdulrahman; Bouchama, Abderrezak; Alharbi, Malak; AlShamrani, Majid; Al Johani, Sameera; Aljeraisy, Majed; Alzahrani, Mohammed; Althaqafi, Abdulhakeem O; Almarhabi, Hassan; Alotaibi, Athari; Alqahtani, Nasser; Arabi, Yaseen M; Aldibasi, Omar S; Alaskar, Ahmad